PC
Patterson Chad Directeur Commercial
OFFICER M
€19,376
▲ Purchases (1 ops.)
Insider track record Executive Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Patterson Chad, Directeur Commercial. Insider active across 2 companies, notably iRhythm Technologies, Inc.. Aggregated, 25 filings have been logged. Split: 1 buy · 16 sells. Total volume traded: €3.5m. History available since 9 September 2021. The latest transaction was filed on 6 August 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations 25 total
2,555 shares @ US$158.97 50.0% of flow Common Stock SEC:0001850152-25-000005
2,555 shares @ US$158.97 0.0061% mcap 50.0% of flow Common Stock SEC:0001850152-25-000005:0
7,210 shares @ US$119.75 37.1% of flow Common Stock SEC:0001388658-25-000109:0
2,756 shares @ US$108.77 14.0% of flow Common Stock SEC:0001388658-25-000064:0
89 shares @ US$72.49 0.3% of flow Common Stock SEC:0001388658-25-000052:0
280 shares @ US$74.98 0.9% of flow Common Stock SEC:0001388658-24-000147:0
Ideal exit: 25 Feb 2025 (T+270) 1,077 shares @ US$111.14 5.4% of flow Common Stock SEC:0001388658-24-000060:0
10,742 shares 0Common Stock SEC:0001388658-24-000045:0
1,896 shares @ US$100.49 8.5% of flow Common Stock SEC:0001388658-23-000097:0
10,674 shares 0Common Stock SEC:0001388658-23-000024:0
21,050 shares 0Common Stock SEC:0001388658-22-000161:0
20,789 shares 0Common Stock SEC:0001388658-22-000117:0
▼ EVP Global Marketing · Executives · 9 May 2022 · DEXCOM INC 777 shares @ US$342.77 0.0010% mcap 17.5% of flow Common Stock SEC:0001093557-22-000102:0
▼ EVP, Global Marketing · Executives · 11 Apr 2022 · DEXCOM INC 776 shares @ US$498.75 0.0014% mcap 24.6% of flow Common Stock SEC:0001093557-22-000088:0
▼ EVP, Global Marketing · Executives · 10 Mar 2022 · DEXCOM INC 776 shares @ US$401.27 0.0011% mcap 19.5% of flow Common Stock SEC:0001093557-22-000061:0
◆ EVP, Global Marketing · Executives · 8 Mar 2022 · DEXCOM INC 5,297 shares @ US$0.001 0.0000% mcap 0.0% of flow Common Stock SEC:0001093557-22-000051:0
▼ EVP, Global Marketing · Executives · 1 Mar 2022 · DEXCOM INC 46 shares @ US$413.97 0.0001% mcap 1.2% of flow Common Stock SEC:0001093557-22-000023:0
◆ EVP, Global Marketing · Executives · 15 Dec 2021 · DEXCOM INC 2,925 shares @ US$0.001 0.0000% mcap 0.0% of flow Common Stock SEC:0001093557-21-000288
◆ EVP, Global Marketing · Executives · 15 Dec 2021 · DEXCOM INC 2,925 shares @ US$0.001 0.0000% mcap 0.0% of flow Common Stock SEC:0001093557-21-000288:0
▼ EVP, Global Marketing · Executives · 13 Oct 2021 · DEXCOM INC 141 shares @ US$545.54 0.0003% mcap 4.6% of flow Common Stock SEC:0001093557-21-000237:0
▼ EVP, Global Marketing · Executives · 13 Oct 2021 · DEXCOM INC 141 shares @ US$545.54 0.0003% mcap 24.6% of flow Common Stock SEC:0001093557-21-000237
▼ EVP, Global Marketing · Executives · 13 Sept 2021 · DEXCOM INC 156 shares @ US$541.47 0.0003% mcap 5.0% of flow Common Stock SEC:0001093557-21-000229:0
▼ EVP, Global Marketing · Executives · 13 Sept 2021 · DEXCOM INC 156 shares @ US$541.47 0.0003% mcap 26.6% of flow Common Stock SEC:0001093557-21-000229
▼ EVP, Global Marketing · Executives · 9 Sept 2021 · DEXCOM INC 287 shares @ US$541.36 0.0005% mcap 48.8% of flow Common Stock SEC:0001093557-21-000217
▼ EVP, Global Marketing · Executives · 9 Sept 2021 · DEXCOM INC 287 shares @ US$541.36 0.0005% mcap 9.1% of flow Common Stock SEC:0001093557-21-000217:0
About Patterson Chad Chad Patterson is the Chief Commercial Officer of iRhythm Technologies, Inc. He is responsible for the sales strategies and revenue growth of the company.